6186N Stock Chart & Stats
$13.58
$0.00(0.00%)
At close: 4:00 PM EDT
$13.58
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$13.58 - $13.58
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$50.13B
Enterprise Value$9.55K
Total Cash (Recent Filing)$15.39B
Total Debt (Recent Filing)$541.21M
Price to Earnings (P/E)11.0
Beta-1.02
Next Earnings
Apr 01, 2027EPS Estimate
0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.20
Shares Outstanding9,067,252,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)1.35
Price to Sales (P/S)1.82
P/FCF Ratio51.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$7.74Price Target Upside-43.02% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.47
Revenue Forecast (FY)$39.67B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage gives Feihe financial resilience and reduces the burden of debt servicing. The sizable equity base can support continued operations and investment through weaker trading conditions, while preserving flexibility for future capital allocation.
Strong Gross MarginsA gross margin near 65% indicates that Feihe retains meaningful product-level economics despite weaker revenue and earnings. This margin base can help absorb operating pressure and provides capacity to support brand investment, product development, and distribution.
Integrated Branded Nutrition ModelFeihe combines branded infant nutrition products with internal research, production, raw-milk sourcing, and supply-chain control. That integrated model can support consistent quality and cost management while reinforcing its position in a focused, recurring consumer nutrition category.
Bears Say
Revenue ContractionThe sharp 2025 revenue decline signals weaker demand, market execution, or product mix than in the prior period. Sustained top-line contraction would reduce operating leverage, limit reinvestment capacity, and make recovery in earnings more dependent on cost control.
Material Margin CompressionThe substantial decline in net margin shows that profitability has weakened beyond the revenue contraction alone. If pricing, mix, or cost pressures persist, Feihe may generate less profit from each sale and have fewer internal resources to strengthen its brand and products.
Weakening Cash ConversionThe steep reduction in free cash flow and conversion indicates that reported earnings are translating into substantially less cash. Lower cash generation can constrain reinvestment and distributions, while increasing the importance of working-capital and investment discipline.
China Feihe Limited News
6186N FAQ
What was China Feihe Limited’s price range in the past 12 months?
China Feihe Limited lowest stock price was $13.58 and its highest was $13.58 in the past 12 months.
What is China Feihe Limited’s market cap?
China Feihe Limited’s market cap is $50.13B.
When is China Feihe Limited’s upcoming earnings report date?
China Feihe Limited’s upcoming earnings report date is Apr 01, 2027 which is in 192 days.
How were China Feihe Limited’s earnings last quarter?
China Feihe Limited released its earnings results on Aug 26, 2026. The company reported $0.23 earnings per share for the quarter, missing the consensus estimate of $0.358 by -$0.128.
Is China Feihe Limited overvalued?
According to Wall Street analysts China Feihe Limited’s price is currently Overvalued.
Does China Feihe Limited pay dividends?
China Feihe Limited does not currently pay dividends.
What is China Feihe Limited’s EPS estimate?
China Feihe Limited’s EPS estimate is 0.26.
How many shares outstanding does China Feihe Limited have?
China Feihe Limited has 9,067,252,000 shares outstanding.
What happened to China Feihe Limited’s price movement after its last earnings report?
China Feihe Limited reported an EPS of $0.23 in its last earnings report, missing expectations of $0.358. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Feihe Limited?
Currently, no hedge funds are holding shares in MX:6186N
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Feihe Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.74 (-43.02% Downside)
$7.74 (-43.02% Downside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.43%
12-Months-Change
Fundamentals
Return on Equity
7.76%
Trailing 12-Months
Asset Growth
7.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
China Feihe Limited
China Feihe Limited operates as an investment holding entity primarily engaged in the production and sale of infant formula, serving consumers across Mainland China and the United States. Its comprehensive product portfolio extends to include raw and liquid milk, adult milk powders, various healthcare products, and specialized powders like soybean and goat milk. Furthermore, the company retails vitamins, minerals, herbal supplements, and other nutritional items. Products reach consumers through a multi-channel approach, utilizing third-party distributors, prominent e-commerce platforms such as Tmall, JD.com, and Suning.com, alongside its official website and mobile applications, including WeChat. By December 31, 2021, its extensive distribution network involved approximately 2,000 offline customers, managing 110,000 retail points of sale. China Feihe Limited was established in 1962 and is headquartered in Beijing, People's Republic of China.
6186N Stock 12 Month Forecast
Average Price Target
$7.74
▼(-43.02% Downside)